Polar Asset Management Partners Inc. lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 26.9% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 29,658 shares of the medical equipment provider's stock after selling 10,900 shares during the quarter. Polar Asset Management Partners Inc.'s holdings in Intuitive Surgical were worth $15,480,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Atala Financial Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at $25,000. Parvin Asset Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $26,000. BankPlus Trust Department acquired a new position in shares of Intuitive Surgical during the 4th quarter worth $28,000. Hurley Capital LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter valued at approximately $28,000. Finally, Summit Securities Group LLC acquired a new position in shares of Intuitive Surgical in the fourth quarter worth $30,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts have recently issued reports on ISRG shares. Piper Sandler decreased their price objective on Intuitive Surgical from $670.00 to $575.00 and set an "overweight" rating on the stock in a report on Wednesday, April 23rd. Barclays decreased their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating for the company in a research note on Thursday, April 24th. Robert W. Baird decreased their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Erste Group Bank lowered Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research report on Monday, March 17th. Finally, Truist Financial lowered their target price on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $596.05.
Check Out Our Latest Analysis on ISRG
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction dated Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares in the company, valued at $2,793,033.06. The trade was a 60.72% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 30,299 shares of company stock worth $15,470,640 in the last ninety days. Company insiders own 0.70% of the company's stock.
Intuitive Surgical Price Performance
Shares of ISRG stock traded up $3.34 during trading hours on Thursday, reaching $555.75. 1,138,240 shares of the company were exchanged, compared to its average volume of 1,643,401. The company has a market cap of $199.19 billion, a price-to-earnings ratio of 86.70, a P/E/G ratio of 5.85 and a beta of 1.70. The stock's fifty day moving average is $514.87 and its two-hundred day moving average is $538.30. Intuitive Surgical, Inc. has a fifty-two week low of $396.15 and a fifty-two week high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, topping the consensus estimate of $1.71 by $0.10. The company had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same quarter in the previous year, the company earned $1.50 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.